|
ALLO Allogene Therapeutics Inc 1737287 |
| Balance Sheet |
|
Current Assets
|
304,415,000 |
|
Assets
|
589,120,000 |
|
Current Liabilities
|
32,571,000 |
|
Liabilities
|
125,372,000 |
|
Equity
|
463,748,000 |
|
Shares Out
|
209,112,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-163,602,000 |
|
Investing Cash Flow
|
20,754,000 |
| Market Analysis |
Market Cap
|
592,831,110 |
|
Price
|
1.68 |
|
BVPS
|
2.22 |
|
PB
|
0.75 |
|
EPS
|
-1.59 |
|
PS
|
5.15 |
|
FCF
|
-142,848,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALLO documents filed with the SEC.
ALLO Filings
Clear
